These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34267303)

  • 1. Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on
    Hirono S; Ozaki K; Kobayashi M; Hara A; Yamaki T; Matsutani T; Iwadate Y
    Sci Rep; 2021 Jul; 11(1):14554. PubMed ID: 34267303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival benefit of lobectomy over gross-total resection without lobectomy in cases of glioblastoma in the noneloquent area: a retrospective study.
    Roh TH; Kang SG; Moon JH; Sung KS; Park HH; Kim SH; Kim EH; Hong CK; Suh CO; Chang JH
    J Neurosurg; 2020 Mar; 132(3):895-901. PubMed ID: 30835701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility study of finalizing the extended adjuvant temozolomide based on methionine positron emission tomography (Met-PET) findings in patients with glioblastoma.
    Hirono S; Hasegawa Y; Sakaida T; Uchino Y; Hatano K; Iuchi T
    Sci Rep; 2019 Nov; 9(1):17794. PubMed ID: 31780768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of recurrence according to the extent of resection in patients with IDH-wild-type glioblastoma: a retrospective study.
    Yoo J; Yoon SJ; Kim KH; Jung IH; Lim SH; Kim W; Yoon HI; Kim SH; Sung KS; Roh TH; Moon JH; Park HH; Kim EH; Suh CO; Kang SG; Chang JH
    J Neurosurg; 2022 Aug; 137(2):533-543. PubMed ID: 34972087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma.
    Vivas-Buitrago T; Domingo RA; Tripathi S; De Biase G; Brown D; Akinduro OO; Ramos-Fresnedo A; Sabsevitz DS; Bendok BR; Sherman W; Parney IF; Jentoft ME; Middlebrooks EH; Meyer FB; Chaichana KL; Quinones-Hinojosa A
    J Neurosurg; 2022 Jan; 136(1):1-8. PubMed ID: 34087795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic delineation of IDH1 wild-type glioblastoma surgical anatomy: how to plan the tumor extent of resection.
    Altieri R; Certo F; Pacella D; Cammarata G; Garozzo M; Broggi G; Caltabiano R; Magro G; Russo G; Cosentino S; Ippolito M; Barbagallo G
    J Neurooncol; 2023 Apr; 162(2):417-423. PubMed ID: 37039952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating genomic signatures into surgical and medical decision-making for elderly glioblastoma patients.
    Ene CI; Cimino PJ; Fine HA; Holland EC
    Neurosurg Focus; 2020 Oct; 49(4):E11. PubMed ID: 33002863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supratotal Resection of Glioblastoma: Better Survival Outcome than Gross Total Resection.
    Baik SH; Kim SY; Na YC; Cho JM
    J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular features of patients with IDH1 wild-type primary glioblastoma presenting unexpected short-term survival after gross total resection.
    Toyoda M; Shibahara I; Shigeeda R; Fujitani K; Tanihata Y; Hyakutake Y; Handa H; Komai H; Sato S; Inukai M; Hide T; Shimoda Y; Kanamori M; Endo H; Saito R; Matsuda KI; Sonoda Y; Kumabe T
    J Neurooncol; 2024 Aug; 169(1):39-50. PubMed ID: 38839702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical supramaximal resection for newly diagnosed left-sided eloquent glioblastoma: safety and improved survival over gross-total resection.
    Di L; Shah AH; Mahavadi A; Eichberg DG; Reddy R; Sanjurjo AD; Morell AA; Lu VM; Ampie L; Luther EM; Komotar RJ; Ivan ME
    J Neurosurg; 2023 Jan; 138(1):62-69. PubMed ID: 35623362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma.
    Tsien CI; Brown D; Normolle D; Schipper M; Piert M; Junck L; Heth J; Gomez-Hassan D; Ten Haken RK; Chenevert T; Cao Y; Lawrence T
    Clin Cancer Res; 2012 Jan; 18(1):273-9. PubMed ID: 22065084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Supratotal Glioblastoma Resection and Patient Survival: A Systematic Review and Meta-Analysis.
    Incekara F; Koene S; Vincent AJPE; van den Bent MJ; Smits M
    World Neurosurg; 2019 Jul; 127():617-624.e2. PubMed ID: 31004858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Super-early initiation of temozolomide prolongs the survival of glioblastoma patients without gross-total resection: a retrospective cohort study.
    Jiang H; Zeng W; Ren X; Cui Y; Li M; Yang K; Elbaroody M; Lin S
    J Neurooncol; 2019 Aug; 144(1):127-135. PubMed ID: 31175579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas.
    Yoo RE; Yun TJ; Hwang I; Hong EK; Kang KM; Choi SH; Park CK; Won JK; Kim JH; Sohn CH
    Eur Radiol; 2020 Feb; 30(2):1202-1211. PubMed ID: 31468161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma.
    Jackson C; Choi J; Khalafallah AM; Price C; Bettegowda C; Lim M; Gallia G; Weingart J; Brem H; Mukherjee D
    J Neurooncol; 2020 Jul; 148(3):419-431. PubMed ID: 32562247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T2 Fluid-Attenuated Inversion Recovery Resection for Glioblastoma Involving Eloquent Brain Areas Facilitated Through Awake Craniotomy and Clinical Outcome.
    Lu M; Fu ZH; He XJ; Lu JK; Deng XQ; Lin DL; Gu YM; Fan YF; Lai MY; Li J; Yang MM; Chen ZP
    World Neurosurg; 2020 Mar; 135():e738-e747. PubMed ID: 31899397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic analysis of patients who underwent gross total resection of newly diagnosed glioblastoma.
    Matsuda M; Kohzuki H; Ishikawa E; Yamamoto T; Akutsu H; Takano S; Mizumoto M; Tsuboi K; Matsumura A
    J Clin Neurosci; 2018 Apr; 50():172-176. PubMed ID: 29396060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes.
    Mampre D; Ehresman J; Pinilla-Monsalve G; Osorio MAG; Olivi A; Quinones-Hinojosa A; Chaichana KL
    Br J Neurosurg; 2018 Oct; 32(5):528-535. PubMed ID: 30073866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.